4-pivaloyloxy-n-methyltryptammonium chloride
AssigneeCaamtech, Inc.
InventorAndrew R. CHADEAYNE
Life of this patent
Estimating the term…
Abstract
The disclosure relates to (2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride), crystalline 4-pivaloyloxy-N-methyltryptammonium chloride, and specific crystalline forms thereof, including crystalline form 1 of 4-pivaloyloxy-N-methyltryptammonium chloride, to compositions containing the same, and to methods of treatment using them.
Claims20
(2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride).
(canceled)
(canceled)
A crystalline form 1 of (2-{4-[(2,2-dimethylpropanoyl)oxy]-1H-indol-3-yl}ethyl)(methyl)azanium chloride (4-pivaloyloxy-N-methyltryptammonium chloride), characterized by at least one of:
- an orthorhombic crystal system at a temperature of about 297 K;
- a Pbca space group at a temperature of about 297 K;
- unit cell dimensions a=17.6586(11) Å, b=9.3207(7) Å, c=20.3054(15) Å, α=900, β=90°, and γ=90°;
- an X-ray powder diffraction pattern substantially similar to FIG. 3;
- or
- an X-ray powder diffraction pattern characterized by at least two peaks selected from 8.7, 11.6, and 13.8° 2θ±0.2° 2θ.
Dependencies are inferred from the claim text.